Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021
HomeMARKET REPORTSGynecological Devices Market

Gynecological Devices Market

December 24, 2020

To Prosper on Back of Rising Global Burden of Gynecological Disorders, Valuation to Touch US$ 25,267.43 Mn by 2027: TMR

Gynecological diseases are the primarily the diseases that involve women’s reproductive system. Globally, these have a high burden and also mortality, such as the prevalence of endometrium cancer and cervical cancer.

Sexually transmitted disease (STD) have been particularly prevalent in the patient population. All these trends shape the prospects of the gynecological devices market.

Rapid advances have been made in both the clinical expertise of surgeons and the devices that are used for minimally invasive surgeries. A case in point is the growing demand for new technologies in devices used in minimally invasive hysterectomies.

Growing demand for gynecological devices in laparoscopy and endoscopy has helped propelled revenue expansion in the market. Globally, the gynecological devices market is expected to reach worth of US$ 25,267.43 Mn, clocking CAGR of 3.8 % from 2019 to 2027.

Request for Analysis of COVID-19 Impact on Gynecological Devices Market – https://www.transparencymarketresearch.com/covid19.php

Key Findings of Gynecological Devices Market

  • In 2018, the global valuation of the market was pegged at US$ 17,449.09 Mn
  • The market is garnering new opportunity from continuing shift to minimally invasive surgeries
  • In the above regard, da Vinci robotic platform and single port laparoscopic surgery (SPLS) are popular approaches
  • Of the various products, surgical device segment held the major share in 2018
  • Regionally, North America held the major share in 2018
  • The North America gynecological devices market is trailed by Europe
  • Opportunities in Asia Pacific expected to make rapid expansion during the forecast period
  • China a potentially lucrative country market in Asia Pacific

Request Brochure of Gynecological Devices Market Report – https://www.transparencymarketresearch.com/brochure.php

Gynecological Devices Market: Key Driving Factors and Promising Avenues

  • Growing severity of gynecological disease is a key trend bolstering the demand in the gynecological devices market
  • Some of the common gynecological conditions are uterine fibroids, ovarian cysts, abnormal vaginal bleeding, genital tract infections, and vagina skin disorders. Over the years, women have growing increasingly aware of the burden of these, and are making clinic visits to address their concerns. This is a key factor underpinning the sales in the gynecological devices market.
  • In developing regions, the burden of HIV and sexually transmitted diseases is high, both due to living working conditions and improving healthcare infrastructure in these parts of the world.
  • The growing incidence of endometrium cancer and its substantial mortality are key factors boosting the demand for minimally invasive surgical procedures in the patient population. Rapid advancements have been brought by medical device makers to make the surgeries minimally invasive.
  • Ovarian cancer, one of the most common cancer in women in the world, has nudged women to give importance to clinical conditions of the related gynecologic diseases.
  • Rapidly increasing traction of robotics and other automation technologies in gynecological disorders has been expanding the avenue in the gynecological devices market.

Purchase the Gynecological Devices Market Report – https://www.transparencymarketresearch.com/checkout.php

Gynecological Devices Market: Competitive Dynamics and Key Impediments for Stakeholders

The regulatory outlook does not seem very favorable to gynecological devices market players in key regions. For instance, the approval policies of the U.S Food and Drug Administration (FDA), such as 510(k) and premarket approval (PMA) norms, need to be more conducive to the marketing of pioneer products. On the other hand, there have been significant number of product recalls vis the PMA processes in the U.S. in the last few years. Moreover, even large medical device manufacturers may be reluctant to bear the cost of stringent documentation.

Nevertheless, medical device makers are leaning on leveraging the strength of robotics surgeries to expand their revenue-earning potential. A large number of players make the landscape increasingly fragmented. Some of the well-entrenched players are Karl Storz Gmbh & Co., Hologic, Inc., Olympus Corporation, Stryker Corporation, and Johnson & Johnson Services.

Explore Transparency Market Research’s award-winning coverage of the global Healthcare Industry:

Contraceptives Market: https://www.transparencymarketresearch.com/contraceptives-market.html

Endoscopy Ultrasound Market: https://www.transparencymarketresearch.com/endoscopy-ultrasound-market.html

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy